Patents by Inventor Henri Laborit

Henri Laborit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation of novel amido-alcohol derivatives and their therapeutic uses
    Patent number: 5391761
    Abstract: Cyclic amido alcohols of formula I are useful in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: July 8, 1993
    Date of Patent: February 21, 1995
    Assignee: Centre d'Etudes Experimentals et Cliniques de Pharmacologie et d'Eutonologie (CEPBEPE)
    Inventors: Henri Laborit, Robert Zerbib, Philippe Dostert
  • Medicament comprising as active ingredient N.sup.6 substituted adenosine
    Patent number: 4906620
    Abstract: New Medicament comprising as active ingredient a N.sup.6 -substituted adenosine of formula I ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen or acyl R.sub.4 -CO- in which R.sub.4 is alkyl, aryl, heteroaryl or aralkyl.
    Type: Grant
    Filed: January 13, 1989
    Date of Patent: March 6, 1990
    Assignee: Centre d'Etudes Experimentales et Cliniques de Physio-Biologie de Pharmacologie et d'Eutonologie (CEPBEPE) and Centre National de la Recherche Scientifique
    Inventors: Henri Laborit, Camille George Wemuth
  • Pyridazine derivatives in alleviating depressive states
    Patent number: 4169158
    Abstract: A class of pyridazine derivatives useful as antidepressants and mood elevators when used in medicine of the formula: ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl group;R.sub.2 is an aryl group such as phenyl or naphthyl or substituted phenyl and N is 2 or 3.Y and Z may be the same or different lower alkyl groups or taken together with the nitrogen atom form a heterocyclic ring wherein Z and Y are lower alkylene radicals cyclized in a ring which contains an oxygen atom linked between them and the other ends of the alkylene chain link to the nitrogen atom. The invention also includes non-toxic acid addition salts thereof suitable for pharmaceutical use and methods for their administration and use as therapeutic agents for humans.
    Type: Grant
    Filed: July 29, 1977
    Date of Patent: September 25, 1979
    Assignee: Centre d'Etudes Experimentales et Cliniques de Physio Biologie de Pharmacologie et d'Eutonologie
    Inventor: Henri Laborit
  • Treatment of hemorrhagic shock
    Patent number: 4049795
    Abstract: A method for the reversal of shock including hemorrhagic shock and elevation of blood pressure in warm blooded animals including man. An injectable solution of from about 20 to 100 mg 1 kilogram of body weight per day of dihydroxy acetone in a glucose-water solution is administered to the patient. The therapeutic composition is in a dosage unit of from 200 to 1600mg/100 cc of dihydroxy acetone in a hypertonic 5 to 20% glucose solution in water.
    Type: Grant
    Filed: May 13, 1974
    Date of Patent: September 20, 1977
    Assignee: Centre d'Etudes Experimentales et Cliniques de Physio Biologie de Pharmacologie et d'Eutonologie
    Inventor: Henri Laborit
  • Medicament
    Patent number: 4035486
    Abstract: New medicament for regulating glycemia comprising guanosine associated with one of the compound of the group comprising acetylcholine and insulin.
    Type: Grant
    Filed: December 11, 1975
    Date of Patent: July 12, 1977
    Assignee: Centre d'Etudes Experimentales et Clinques de Physio Biologie, de Pharmacologie et d'Eutonologie, C.E.P.B.E.P.E.
    Inventor: Henri Laborit